参考文献

1.陈杰，周桥 .病理学 .3版 .北京 :人民卫生出版社，2015

2.刘彤华 .诊断病理学 .3版 .北京 :人民卫生出版社，2013

3.邹仲之，李继承 .组织学与胚胎学 .8版 .北京 :人民卫生出版社，2013

4.琳达·D·法瑞尔，桑迪·卡加 .肝脏病理学 .天津 :天津科技翻译出版有限公司，2015

5.陈东风，孙文静，熊吉 .药物性肝损伤的诊断与治疗 .中华肝脏病杂志，2013，20（3）:170-172

6.马雄 .自身免疫性肝病的诊治 :从共识到指南 .中华肝脏病杂志，2016，24（1）:3-4

7.中华医学会肝病学分会药物性肝病学组 .药物性肝损伤诊治指南 .中华肝脏病杂志，2015，23（11）:810-820

8.中华医学会肝病学分会 .自身免疫性肝炎诊断和治疗共识（2015）.中华肝脏病杂志，2016，24（1）:23-35

9.赵素贤，张玉果，谭普芳，等.药物诱导的自身免疫性肝炎与药物性肝损伤的临床特征对照研究.中华肝脏病杂志，2016，24（4）:302-306

10.Abbas Z，Shazi L.Pattern and profile of chronic liver disease in acute on chronic liver failure.Hepatol Int，2015，3:366-372

11.Almpanis Z，Demonakou M，Tiniakos D.Evaluation of liver fibrosis:“Something old，something new…”.Ann Gastroenterol，2016，29（4）:445-453

12.Cooper C.Hepatitis C treatment highlights from the 2011 American Association for the Study of Liver Disease meeting.Clin Infect Dis，2012，55（3）:418-425

13.Hyams C，Mabayoje DA，Copping R，et al.Serological cross reactivity to CMV Van der Poel WH.Food and environmental routes of Hepatitis E virus transmission.Curr Opin Virol，2014，4:91-96

14.Iwasaki A，Sakai K，Moriya K，et al.Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis.J Biol Chem，2016，291（1）:72-88

15.Kawashima N，Muramatsu H，Okuno Y，et al.Fulminant adenovirus hepatitis after hematopoietic stem cell transplant:Retrospective real-time PCR analysis for adenovirus DNA in two cases.J Infect Chemother，2015，21（12）:857-883

16.Kerensky T，Hasan A，Schain D，et al.Histopathologic resolution of adult liver transplantation adenovirus hepatitis with cidofovir and intravenous immunoglobulin:a case report.Transplant Proc，2013，45（1）:293-296

17.Katarey D，Verma S.Drug-induced liver injury.Clin Med（Lond），2016，16（Suppl 6）:s104-s109

18.Lurie Y，Webb M，Cytter-Kuint R，et al.Non-invasive diagnosis of liver fibrosis and cirrhosis.World J Gastroenterol，2015，21（41）:11567-11583

19.Montano-Loza AJ，Thandassery RB，Czaja AJ.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Dig Dis Sci，2016，61（11）:3118-3139

20.Mirazo S，Ramos N，Mainardi V，et al.Transmission，diagnosis，and management of hepatitis E:an update.Hepat Med，2014，6:45-59

21.Patel I，Ching Companioni R，Bansal R，et al.Acute hepatitis E presenting with clinical feature of autoimmune hepatitis.J Community Hosp Intern Med Perspect，2016，6（6）:33342

22.Puustinen L，Boyd S，Mustonen H，et al.Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis.Scand J Gastroenterol，2016，16:1-7

23.Shigefuku R，Takahashi H，Nakano H，et al.Correlations of Hepatic Hemodynamics，Liver Function，and Fibrosis Markers in Nonalcoholic Fatty Liver Disease:Comparison with Chronic Hepatitis Related to Hepatitis C Virus.Int J Mol Sci，2016，17（9）:E1545

24.Sahai S，Kiran R.Acute liver failure in pregnancy:causative and prognostic factors.Saudi J Gastroenterol，2015，21（1）:30-33

25.Tujios SR，Lee WM.Update in the management of chronic hepatitis B.Curr Opin Gastroenterol，2013，29（3）:250-256

26.Vine LJ，Shepherd K，Hunter JG，et al.Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis.Aliment Pharmacol Ther，2012，36（1）:16-21

27.Yang SI，Geong JH，Kim JY.Clinical characteristics of primary Epstein Barr virus hepatitis with elevation of alkaline phosphatase and γ-glutamyltransferase in Children.Yonsei Med J，2014，55（1）:107-112

28.Wang L，Liu L，Wei Y，et al.Clinical and virological profiling of sporadic hepatitis E virus infection in China.J Infect，2016，73（3）:271-279 uzytEGfPiyihjgLJE/pt7cAGEiRgb2Sw7rSdhA9vW2/cyLmnuGFhz7tunfkn5/ee